These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8594442)

  • 1. Alendronate in postmenopausal osteoporosis.
    Liedholm H; Linné AB
    N Engl J Med; 1996 Mar; 334(11):733-4; author reply 734-5. PubMed ID: 8594442
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 3. Alendronate.
    Hamdy RC
    South Med J; 1999 Nov; 92(11):1118-20. PubMed ID: 10586845
    [No Abstract]   [Full Text] [Related]  

  • 4. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
    MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
    [No Abstract]   [Full Text] [Related]  

  • 7. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 8. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meds hiatus won't hurt your hips. Five years on, five years off: taking a break from Fosamax won't result in broken bones.
    Duke Med Health News; 2007 Apr; 13(4):5. PubMed ID: 17441274
    [No Abstract]   [Full Text] [Related]  

  • 10. [Osteoporosis. Fracture as alarm signal].
    MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
    Delmas PD; Rizzoli R; Cooper C; Reginster JY
    Osteoporos Int; 2005 Jan; 16(1):1-5. PubMed ID: 15565349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Number of patients to be treated and number of prevented fractures: clinical efficiency of osteoporosis treatment with diphosphonate alendronate].
    Riancho JA
    Rev Clin Esp; 1999 Jun; 199(6):349-55. PubMed ID: 10432808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alendronate (Fosamax 10 mg). The first amino-biphosphate for the treatment of women with postmenopausal osteoporosis].
    Geburtshilfe Frauenheilkd; 1996 Oct; 56(10 Suppl):1-4. PubMed ID: 9022376
    [No Abstract]   [Full Text] [Related]  

  • 18. Alendronate in postmenopausal osteoporosis.
    McGrath H
    N Engl J Med; 1996 Mar; 334(11):734; author reply 734-5. PubMed ID: 8594443
    [No Abstract]   [Full Text] [Related]  

  • 19. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
    Compston JE
    Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.